330 related articles for article (PubMed ID: 7472590)
1. Technetium-99m-tetrofosmin in dipyridamole-stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestamibi.
Flamen P; Bossuyt A; Franken PR
J Nucl Med; 1995 Nov; 36(11):2009-15. PubMed ID: 7472590
[TBL] [Abstract][Full Text] [Related]
2. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease.
Münch G; Neverve J; Matsunari I; Schröter G; Schwaiger M
J Nucl Med; 1997 Mar; 38(3):428-32. PubMed ID: 9074532
[TBL] [Abstract][Full Text] [Related]
3. Technetium-99m sestamibi and tetrofosmin myocardial single-photon emission tomography: can we use the same reference data base?
Widding A; Hesse B; Gadsboll N
Eur J Nucl Med; 1997 Jan; 24(1):42-5. PubMed ID: 9044875
[TBL] [Abstract][Full Text] [Related]
4. Assessing coronary artery disease with dipyridamole technetium-99m-tetrofosmin SPECT: a multicenter trial.
He ZX; Iskandrian AS; Gupta NC; Verani MS
J Nucl Med; 1997 Jan; 38(1):44-8. PubMed ID: 8998148
[TBL] [Abstract][Full Text] [Related]
5. Tc-99m tetrofosmin myocardial perfusion SPECT after dipyridamole combined with low-level exercise in the diagnosis of coronary artery disease.
Fukuzawa S; Ozawa S; Inagaki M; Inoue T; Morooka S; Sugioka J
Ann Nucl Med; 1996 May; 10(2):231-5. PubMed ID: 8800453
[TBL] [Abstract][Full Text] [Related]
6. Myocardial viability assessment with technetium-99m-tetrofosmin and thallium-201 reinjection in coronary artery disease.
Matsunari I; Fujino S; Taki J; Senma J; Aoyama T; Wakasugi T; Hirai J; Saga T; Ichiyanagi K; Hisada K
J Nucl Med; 1995 Nov; 36(11):1961-7. PubMed ID: 7472582
[TBL] [Abstract][Full Text] [Related]
7. Quantitative comparison of single-isotope and dual-isotope stress-rest single-photon emission computed tomographic imaging for reversibility of defects.
Siebelink HM; Natale D; Sinusas AJ; Wackers FJ
J Nucl Cardiol; 1996; 3(6 Pt 1):483-93. PubMed ID: 8989673
[TBL] [Abstract][Full Text] [Related]
8. Technetium-99m sestamibi myocardial imaging: same-day rest-stress studies and dipyridamole.
Taillefer R
Am J Cardiol; 1990 Oct; 66(13):80E-84E. PubMed ID: 2145751
[TBL] [Abstract][Full Text] [Related]
9. Quantitative comparison of planar and SPECT normal data files of thallium-201, technetium-99m-sestamibi, technetium-99m-tetrofosmin and technetium-99m-furifosmin.
Naruse H; Daher E; Sinusas A; Jain D; Natale D; Mattera J; Makuch R; Wackers FJ
J Nucl Med; 1996 Nov; 37(11):1783-8. PubMed ID: 8917175
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of dipyridamole technetium 99m-labeled sestamibi myocardial tomography for detection of coronary artery disease.
Miller DD; Younis LT; Chaitman BR; Stratmann H
J Nucl Cardiol; 1997; 4(1 Pt 1):18-24. PubMed ID: 9138835
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography.
Sandler MP; Videlefsky S; Delbeke D; Patton JA; Meyerowitz C; Martin WH; Ohana I
J Am Coll Cardiol; 1995 Oct; 26(4):870-8. PubMed ID: 7560611
[TBL] [Abstract][Full Text] [Related]
12. Detection of coronary artery disease: comparison between technetium 99m-labeled sestamibi single-photon emission computed tomography and two-dimensional echocardiography with dipyridamole low-level exercise-stress.
Cramer MJ; van der Wall EE; Jaarsma W; Verzijlbergen JF; Niemeyer MG; Zwinderman AH; Pauwels EK
J Nucl Cardiol; 1996; 3(5):389-94. PubMed ID: 8902670
[TBL] [Abstract][Full Text] [Related]
13. Are technetium-99m-labeled myocardial perfusion agents adequate for detection of myocardial viability?
Caner B; Beller GA
Clin Cardiol; 1998 Apr; 21(4):235-42. PubMed ID: 9562932
[TBL] [Abstract][Full Text] [Related]
14. Myocardial single-photon emission computed tomographic imaging with technetium 99m tetrofosmin: stress-rest imaging with same-day and separate-day rest imaging.
Sridhara B; Sochor H; Rigo P; Braat S; Itti R; Martinez-Duncker D; Cload P; Lahiri A
J Nucl Cardiol; 1994; 1(2 Pt 1):138-43. PubMed ID: 9420680
[TBL] [Abstract][Full Text] [Related]
15. [Whole body distribution of Tc-99m-sestamibi after pharmacological stress with arbutamine and dipyridamole compared with resting conditions].
Kotzerke J; Bergmann K; Glatz S; Höher M; Reske SN
Nuklearmedizin; 1997 Jan; 36(1):19-22. PubMed ID: 9082336
[TBL] [Abstract][Full Text] [Related]
16. Comparative feasibility of separate or simultaneous rest thallium-201/stress technetium-99m-sestamibi dual-isotope myocardial perfusion SPECT.
Kiat H; Germano G; Friedman J; Van Train K; Silagan G; Wang FP; Maddahi J; Berman D
J Nucl Med; 1994 Apr; 35(4):542-8. PubMed ID: 8151372
[TBL] [Abstract][Full Text] [Related]
17. Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol.
Jain D; Wackers FJ; Mattera J; McMahon M; Sinusas AJ; Zaret BL
J Nucl Med; 1993 Aug; 34(8):1254-9. PubMed ID: 8326381
[TBL] [Abstract][Full Text] [Related]
18. Comparison of single-tracer (technetium-99m-sestamibi) and dual-tracer (thallium-201 chloride and technetium-99m-sestamibi) protocols for identification of myocardial ischemia.
Loutfi I; Singh A
Invest Radiol; 1995 Jun; 30(6):367-71. PubMed ID: 7490189
[TBL] [Abstract][Full Text] [Related]
19. [Clinical usefulness of dipyridamole loading 99mTc-tetrofosmin myocardial scintigraphy].
Adachi I; Sugioka Y; Tabuchi K; Namba R; Nakata Y; Nishigaki H; Matsui R; Sueyoshi K; Narabayashi I; Ohkubo T
Kaku Igaku; 1995 Sep; 32(9):943-51. PubMed ID: 8523842
[TBL] [Abstract][Full Text] [Related]
20. Technetium 99m sestamibi in the assessment of chronic coronary artery disease.
Berman DS; Kiat H; Van Train K; Garcia E; Friedman J; Maddahi J
Semin Nucl Med; 1991 Jul; 21(3):190-212. PubMed ID: 1835137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
